Market Research Report World Chemotherapy Induced Nausea and Vomiting (CI | Page 2

Description Scope of the Report The report titled“ Global Chemotherapy Induced Nausea & Vomiting( CINV) Market: Size, Trends & Forecasts( 2016-2020)”, provides and in-depth analysis of the global CINV market and respective drugs. The report gives an insight of the global CINV market by 5-HT3 and NK-1 drug receptor antagonists.
Purchase a copy of Global Chemotherapy Induced Nausea and Vomiting( CINV) Market visit @ http:// www. orbisresearch. com / contact / purchase / 185419.
The report also includes the analysis of North American CINV market. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global CINV market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The competition in global CINV market is fragmented as the specific treatment for CINV is still at a nascent stage with several drugs by multiple competitors already thriving the market and some are under formulation.
The key players of the global CINV market, Heron Therapeutics, Inc., Merck & Co., Inc., Novartis AG and TESARO, Inc. are also profiled with their financial information and respective business strategies
Country Coverage North America
Company Coverage Heron Therapeutics, Inc. Merck & Co., Inc. Novartis AG TESARO, Inc.
Executive Summary Chemotherapy induced nausea and vomiting( CINV) is the most dreaded side-effect of chemotherapy among the cancer patients. Therefore, sometimes patients either do not undergo the chemotherapy or discontinue in the prior year of treatment. CINV is also of various types such as acute, breakthrough, delayed, anticipatory and refractory. HEC and MEC regimens cause the CINV. Several treatments of CINV are on the verge of emergence such as 5-HT3 receptor antagonist, NK-1 blocker, corticosteroids, cannabinoids and dopamine antagonists. However, there are several unmet medical needs in the field of HEC regimen of delayed CINV.
Get More Information of Global Chemotherapy Induced Nausea and Vomiting( CINV) Market Report @ http:// www. orbisresearch. com / reports / index / global-chemotherapy-induced-nausea-andvomiting-cinv-market-size-trends-and-forecasts-2016-2020.
www. orbisresearch. com; + 1( 214) 884-6817; + 9120-64101019